Advertisement
ICUI vs NSYS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICUI is a Buy and NSYS is a StrongBuy.
Aroon Indicator for ICUI shows an upward move is likely
ICUI's Aroon Indicator triggered a bullish signal on October 22, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 205 similar instances where the Aroon Indicator showed a similar pattern. In 155 of the 205 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ICUI's RSI Indicator exited the oversold zone, 22 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 69%.
The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on ICUI as a result. In 63 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 68%.
The Moving Average Convergence Divergence (MACD) for ICUI just turned positive on September 24, 2026. Looking at past instances where ICUI's MACD turned positive, the stock continued to rise in 36 of 51 cases over the following month. The odds of a continued upward trend are 71%.
ICUI moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +4.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in 193 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
Bearish Trend Analysis
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 36 of 59 cases where ICUI's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 61%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
ICUI broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.956) is normal, around the industry mean (4.961). ICUI has a moderately high P/E Ratio (140.275) as compared to the industry average of (37.232). Projected Growth (PEG Ratio) (0.081) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.808) is also within normal values, averaging (56.876).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
NSYS's RSI Oscillator ascends from oversold territory
The RSI Indicator for NSYS moved out of oversold territory on October 20, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 25 similar instances when the indicator left oversold territory. In 23 of the 25 cases the stock moved higher. This puts the odds of a move higher at 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 60 cases where NSYS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 75%.
Following a +8.36% 3-day Advance, the price is estimated to grow further. Considering data from situations where NSYS advanced for three days, in 181 of 233 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
NSYS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NSYS as a result. In 79 of 105 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for NSYS turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 40 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
The 50-day moving average for NSYS moved below the 200-day moving average on October 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NSYS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
The Aroon Indicator for NSYS entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. NSYS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.822) is normal, around the industry mean (2.874). P/E Ratio (27.405) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.267) is also within normal values, averaging (40.124).
The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NSYS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
ICUI | NSYS | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 71 | 55 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 87 Overvalued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 89 | 87 | |
PRICE GROWTH RATING 1..100 | 41 | 63 | |
P/E GROWTH RATING 1..100 | 96 | 59 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NSYS's Valuation (74) in the Electronic Components industry is in the same range as ICUI (87) in the Medical Specialties industry. This means that NSYS’s stock grew similarly to ICUI’s over the last 12 months.
NSYS's Profit vs Risk Rating (100) in the Electronic Components industry is in the same range as ICUI (100) in the Medical Specialties industry. This means that NSYS’s stock grew similarly to ICUI’s over the last 12 months.
NSYS's SMR Rating (87) in the Electronic Components industry is in the same range as ICUI (89) in the Medical Specialties industry. This means that NSYS’s stock grew similarly to ICUI’s over the last 12 months.
ICUI's Price Growth Rating (41) in the Medical Specialties industry is in the same range as NSYS (63) in the Electronic Components industry. This means that ICUI’s stock grew similarly to NSYS’s over the last 12 months.
NSYS's P/E Growth Rating (59) in the Electronic Components industry is somewhat better than the same rating for ICUI (96) in the Medical Specialties industry. This means that NSYS’s stock grew somewhat faster than ICUI’s over the last 12 months.
| ICUI | NSYS | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 69% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 61% | 1 day ago 75% |
| Momentum ODDS (%) | 1 day ago 68% | 1 day ago 75% |
| MACD ODDS (%) | 1 day ago 71% | 1 day ago 83% |
| TrendWeek ODDS (%) | 1 day ago 69% | 1 day ago 75% |
| TrendMonth ODDS (%) | 1 day ago 73% | 1 day ago 72% |
| Advances ODDS (%) | 11 days ago 68% | 2 days ago 78% |
| Declines ODDS (%) | 2 days ago 71% | 4 days ago 74% |
| BollingerBands ODDS (%) | 1 day ago 72% | 1 day ago 87% |
| Aroon ODDS (%) | 1 day ago 76% | 1 day ago 70% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ICUI’s FA Score shows that 0 FA rating(s) are green while NSYS’s FA Score has 0 green FA rating(s).
- ICUI’s FA Score: 0 green, 5 red.
- NSYS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ICUI’s TA Score shows that 6 TA indicator(s) are bullish while NSYS’s TA Score has 4 bullish TA indicator(s).
- ICUI’s TA Score: 6 bullish, 3 bearish.
- NSYS’s TA Score: 4 bullish, 5 bearish.
Price Growth
ICUI (@Pharmaceuticals: Other) experienced а +0.66% price change this week, while NSYS (@Medical/Nursing Services) price change was +0.38% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.59%. For the same industry, the average monthly price growth was -3.91%, and the average quarterly price growth was +7.47%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
Reported Earning Dates
ICUI is expected to report earnings on Nov 05, 2026.
NSYS is expected to report earnings on Nov 12, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+0.59% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (-1.62% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
ICUI and
Correlation & Price change
A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.
| Ticker / NAME | Correlation To ICUI | 1D Price Change % | ||
|---|---|---|---|---|
| ICUI | 100% | +4.66% | ||
| CLPT - ICUI | 57% Loosely correlated | N/A | ||
| ALGN - ICUI | 50% Loosely correlated | +2.74% | ||
| MMSI - ICUI | 50% Loosely correlated | +2.78% | ||
| A - ICUI | 50% Loosely correlated | -2.17% | ||
| BLCO - ICUI | 49% Loosely correlated | +1.46% | ||
More | ||||
NSYS and
Correlation & Price change
A.I.dvisor tells us that NSYS and STRR have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NSYS and STRR's prices will move in lockstep.
| Ticker / NAME | Correlation To NSYS | 1D Price Change % | ||
|---|---|---|---|---|
| NSYS | 100% | -4.61% | ||
| STRR - NSYS | 29% Poorly correlated | -0.92% | ||
| POCI - NSYS | 26% Poorly correlated | -1.86% | ||
| STRRP - NSYS | 23% Poorly correlated | +3.16% | ||
| LH - NSYS | 23% Poorly correlated | +1.91% | ||
| ICUI - NSYS | 23% Poorly correlated | +4.66% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| IBIH | 25.28 | 0.14 | +0.58% |
| iShares iBonds Oct 2031 Term TIPS ETF (IBIH) | |||
| TDTT | 23.53 | 0.10 | +0.43% |
| Northern Trust iBoxx 3-Year Target Duration TIPS ETF (TDTT) | |||
| DFEB | 51.79 | -0.25 | -0.48% |
| FT Vest U.S. Equity Deep Buffer ETF - February (DFEB) | |||
| AIUP | 27.95 | -1.23 | -4.20% |
| Finq First U.S. Large Cap AI Managed Equity ETF | |||
| QTAC | 23.51 | -1.15 | -4.67% |
| Q3 All-Season Tactical Advantage ETF (QTAC) | |||